Free Trial

DocuSign, Inc. (NASDAQ:DOCU) Shares Purchased by Quantinno Capital Management LP

DocuSign logo with Computer and Technology background

Quantinno Capital Management LP grew its position in DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 17.5% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 236,829 shares of the company's stock after purchasing an additional 35,283 shares during the period. Quantinno Capital Management LP owned about 0.12% of DocuSign worth $21,300,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Rhumbline Advisers grew its position in DocuSign by 118.8% in the fourth quarter. Rhumbline Advisers now owns 608,123 shares of the company's stock valued at $54,695,000 after purchasing an additional 330,136 shares in the last quarter. KBC Group NV lifted its stake in shares of DocuSign by 32.7% during the 4th quarter. KBC Group NV now owns 1,535,107 shares of the company's stock worth $138,067,000 after buying an additional 378,233 shares during the last quarter. Jennison Associates LLC acquired a new stake in shares of DocuSign during the 4th quarter worth about $12,897,000. Principal Financial Group Inc. boosted its holdings in DocuSign by 3,026.7% in the 4th quarter. Principal Financial Group Inc. now owns 546,796 shares of the company's stock valued at $49,179,000 after purchasing an additional 529,308 shares during the period. Finally, Amundi boosted its holdings in DocuSign by 565.8% in the 4th quarter. Amundi now owns 1,379,575 shares of the company's stock valued at $123,486,000 after purchasing an additional 1,172,368 shares during the period. 77.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

DOCU has been the topic of several research reports. William Blair reaffirmed an "outperform" rating on shares of DocuSign in a report on Monday, April 21st. Morgan Stanley dropped their target price on shares of DocuSign from $97.00 to $92.00 and set an "equal weight" rating on the stock in a research report on Wednesday, April 16th. Wells Fargo & Company lowered their price objective on shares of DocuSign from $73.00 to $65.00 and set an "underweight" rating on the stock in a report on Tuesday, April 22nd. Robert W. Baird set a $93.00 target price on shares of DocuSign in a research note on Friday, March 14th. Finally, Hsbc Global Res upgraded shares of DocuSign from a "moderate sell" rating to a "hold" rating in a research report on Friday, April 11th. One research analyst has rated the stock with a sell rating, eleven have issued a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $92.46.

Read Our Latest Research Report on DocuSign

Insider Buying and Selling

In other news, CFO Blake Jeffrey Grayson sold 16,111 shares of the firm's stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $83.20, for a total transaction of $1,340,435.20. Following the sale, the chief financial officer now owns 93,960 shares of the company's stock, valued at approximately $7,817,472. This trade represents a 14.64% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Teresa Briggs sold 534 shares of the firm's stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $87.41, for a total value of $46,676.94. Following the transaction, the director now owns 8,270 shares in the company, valued at $722,880.70. This represents a 6.07% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 47,851 shares of company stock worth $3,912,239. 1.66% of the stock is owned by corporate insiders.

DocuSign Stock Performance

DOCU stock traded up $1.87 during midday trading on Friday, reaching $92.42. The company's stock had a trading volume of 2,010,367 shares, compared to its average volume of 2,753,903. The firm has a market capitalization of $18.72 billion, a price-to-earnings ratio of 19.06, a PEG ratio of 6.94 and a beta of 1.21. DocuSign, Inc. has a 1 year low of $48.70 and a 1 year high of $107.86. The stock has a fifty day simple moving average of $81.19 and a two-hundred day simple moving average of $85.09.

DocuSign (NASDAQ:DOCU - Get Free Report) last issued its quarterly earnings results on Thursday, March 13th. The company reported $0.86 earnings per share for the quarter, topping the consensus estimate of $0.84 by $0.02. DocuSign had a return on equity of 14.90% and a net margin of 34.73%. The business had revenue of $776.25 million during the quarter, compared to the consensus estimate of $760.94 million. During the same quarter last year, the company earned $0.76 earnings per share. The company's quarterly revenue was up 9.0% on a year-over-year basis. As a group, analysts forecast that DocuSign, Inc. will post 1.17 EPS for the current fiscal year.

About DocuSign

(Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Recommended Stories

Institutional Ownership by Quarter for DocuSign (NASDAQ:DOCU)

Should You Invest $1,000 in DocuSign Right Now?

Before you consider DocuSign, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.

While DocuSign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

New AI Deals Just Sent These 4 Infrastructure Stocks Soaring
7 Nuclear Stocks One Announcement Away from Exploding
3 AI ETFs for Steady Gains in 2025 (Without the Wild Volatility)

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines